Connect with us

Technology

10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting

Published

on

PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ — At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis.

During its Foundational Sponsor talk in the Sept. 29 Technology Showcase, 10x Genomics announced an imminent plan to deliver “single cell for a single cent.” Through a series of new products and configurations expected to launch this quarter, 10x Genomics intends to deliver mega-scale single cell analysis at a cost as low as $0.01 per cell. 10x Genomics believes its upcoming launches, which enable 2.5 million cells per run and 5 million cells per kit, will be the most cost effective single cell products available for CRISPR screens, cell atlassing projects and other high-throughput applications.

“We know price is an important consideration, both for new researchers embarking on their first single cell experiment and current customers looking to do more – whether that’s analyzing more cells or more samples, or running more experiments, more routinely,” said Michael Schnall-Levin, Founding Scientist and Chief Technology Officer at 10x Genomics. “By continuing to deliver single cell technologies that offer superior performance and superior economics, we believe we can expand the single cell opportunity, drive widespread adoption and make single cell analysis the standard for most biological research.”

In addition to new solutions for mega-scale applications, 10x Genomics’ planned launches this quarter will feature cost effective products to increase access to and adoption of single cell in additional applications and use cases. These new offerings are expected to enable researchers to perform single cell experiments, even at a small scale, for approximately $560 per sample.

As part of the company’s strategy to democratize access to single cell analysis, 10x Genomics introduced several new products earlier this year to drive down customer cost in multiple directions: per cell, per sample, per experiment and per project. This includes:

Chromium GEM-X Technology: In March, 10x Genomics launched the first two products on its new GEM-X technology architecture, which enables increased sensitivity and capture efficiency, improved robustness and scalability and a more than two-fold reduction in cost per cell.

Chromium Xo: Last month, 10x Genomics announced the launch of Chromium Xo, the company’s most affordable single cell instrument. Chromium Xo delivers the high-quality data, superior reproducibility and ease of use that the company’s instrument-powered workflows are known for, at a U.S. list price of $25,000.

“For nearly a decade, researchers have known 10x as the single cell technology leader,” added Schnall-Levin. “Our upcoming launches will reinforce Chromium’s leadership in both high performance and low cost, because researchers should never have to compromise one for the other. We can’t wait to show the world what we’ve been working on.”

About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the “safe harbor” provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “see,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding 10x Genomics, Inc.’s (“10x Genomics”) and others’ product launches, performance, configuration, costs, capabilities, requirements, workflows, applications, adoption, opportunities, leadership and pipeline. These statements are based on management’s current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. Other risks and uncertainties that could affect 10x Genomics’ financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents 10x Genomics files with the Securities and Exchange Commission (the “SEC”) from time to time. Although 10x Genomics believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to 10x Genomics as of the date hereof, and 10x Genomics disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics’ views as of any date subsequent to the date of this press release.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-announces-mega-scale-single-cell-analysis-for-one-cent-per-cell-at-human-cell-atlas-general-meeting-302264693.html

SOURCE 10x Genomics, Inc.

Continue Reading

Technology

Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation

Published

on

By

Initiative establishes new Gemini Frontier Capability Group, dedicating more than 18,000 engineers to help drive AI adoption for global enterprises.More than 55,000 associates completed Build with Gemini, the largest Gemini partner workshop held to date, part of a shared commitment to scale client execution through Cognizant’s Frontier Certified Engineers.

TEANECK, N.J. and SUNNYVALE, Calif., Oct. 19, 2026 /PRNewswire/ — Cognizant (Nasdaq: CTSH) and Google Cloud today announced a significant expansion of their partnership to accelerate the adoption of agentic AI, including a new Gemini Frontier Capability Group. The group brings together a dedicated global workforce that pairs Google’s full-stack, enterprise-ready AI platform with Cognizant’s domain, industry and engineering expertise as an AI Builder.

Backed by more than 18,000 dedicated Cognizant associates, the new group represents a substantial joint investment and builds on the momentum created by Cognizant’s dedicated Gemini practice launched in April 2026. The new group is designed to bridge the path from pilot to production, equipping enterprises with the ability to safely deploy resilient, enterprise-grade agents that can help drive measurable business value.

“Establishing our dedicated Gemini Frontier Capability Group lets our best frontier engineering talent focus entirely on getting frontier AI into production for clients,” said Ravi Kumar S, CEO of Cognizant. “Our Build with Gemini workshop gave over 55,000 associates that experience directly, earning them tangible skills on one of the world’s most advanced AI platforms, and this new group is where that experience goes to work every day.”

“Deploying AI agents at scale requires trusted partners with deep architectural and integration expertise,” said Thomas Kurian, chief executive officer, Google Cloud. “Cognizant’s dedicated Frontier Capability Group and their skilling initiative for tens of thousands of engineers on Gemini will help our joint customers accelerate the adoption of autonomous agents throughout the enterprise.”

Introducing the Gemini Frontier Capability Group

Designed to meet surging enterprise demand for scaled AI execution, the group aims to deliver production-grade, AI solutions designed to drive business outcomes for global enterprises by leveraging Gemini, Google Cloud’s AI platform for building, governing, and deploying agents. The group will initially concentrate its engineering capabilities across legacy modernization, developer experience, autonomous business process agentification and frontier cyber defense.

To operationalize these capabilities, the group plans to deploy standardized, security-first agentic architecture built on the Model Context Protocol (MCP) and fortified by Google Cloud’s Model Armor. These trusted frameworks are expected to power a new suite of collaborative, production-ready enterprise solutions, including Cognizant’s Catalog Support Agent (CSA) for retail, the Neuro® San-orchestrated Healthcare Agentic Marketplace, and multi-agent Order-to-Cash (O2C) workflows for manufacturing.

Scaling outcomes with Frontier Certified Engineers

Underpinning the group is a shared commitment by Google Cloud and Cognizant to scale client execution through Frontier Certified Engineers. One early proof point shows what this looks like in practice: by integrating Gemini AI models across its software development lifecycle, Cognizant helped a leading retailer achieve a 40% increase in developer productivity, reduce time-to-market by 30%, and realize a 35% cost savings, underscoring the transformative potential of AI-driven software engineering.

As part of Cognizant’s frontier certification skills drive, the company recently concluded the Build with Gemini workshop with Google Cloud, where Cognizant associates built AI agents and applications while earning Gemini skills credentials. Completed by more than 55,000 Cognizant associates, it is the largest single Gemini partner workshop held to date, representing a meaningful step in building Cognizant’s frontier-certified workforce.

Cognizant is also applying Gemini internally at scale. As announced in July, the company is deploying Gemini to 100,000 associates this year, with plans to scale up to 200,000, and continues to increase its certification commitment for professionals on the platform.

About Cognizant
Cognizant (Nasdaq: CTSH) is an AI Builder and technology services provider, bridging the gap between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization’s unique context into technology systems that amplify human potential, drive tangible outcomes and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant. 

About Google Cloud
Google Cloud offers a powerful, optimized AI stack — including AI infrastructure, leading models like Gemini, data management capabilities, multicloud security solutions, developer tools and platform, as well as agents and applications — that enables organizations to transform their business for the Agentic Era. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner.

Cognizant media contacts:

U.S.

Name Ben Gorelick

Email benjamin.gorelick@cognizant.com 

Europe / APAC

Name Sarah Douglas

Email sarah.douglas@cognizant.com 

India

Name Vipin Nair

Email Vipin.nair@cognizant.com 

Google Cloud media contact:

   Josh Gunter

   jmgunter@google.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-and-google-cloud-expand-alliance-to-accelerate-agentic-enterprise-transformation-302912036.html

SOURCE Cognizant Technology Solutions

Continue Reading

Technology

Eczema Awareness Month 2026: What Is the State of Eczema Today?

Published

on

By

NEA pairs findings from its State of AD report with video stories from the community to highlight the data and daily realities of living with eczema

For Eczema Awareness Month 2026, NEA asks what living with eczema looks like today, drawing on the State of AD to bring national data and personal stories together.

The State of Atopic Dermatitis Indicator Report and 51 state-level briefs, published Oct. 1, are available at StateofAD.org.

Video stories from people with eczema and their caregivers share what daily life with the condition is like. Join the conversation with #UnhideEczema.

NOVATO, Calif., Oct. 19, 2026 /PRNewswire/ — Eczema Awareness Month 2026 is underway, and this year’s theme is the State of Eczema. Since Oct. 1, the National Eczema Association (NEA) has been inviting the community to see, share and talk about what living with eczema is like. Throughout October, NEA is asking a question for the more than 31 million Americans living with eczema, and those who care for them: what is it like to live with eczema, and what does it take to get good care?

The theme builds on the State of AD, NEA’s four-year initiative on atopic dermatitis (AD), funded by the Centers for Disease Control and Prevention (CDC). It brings together two kinds of evidence, national data and the experiences of people with eczema, to offer a more complete view of the condition.

The State of AD: data that backs up the experience

On Oct. 1, NEA published its State of Atopic Dermatitis Indicator Report, along with 51 state-level briefs covering all 50 states and Washington, D.C. AD is the most common form of eczema. The report is the first comprehensive national and state-level baseline on AD diagnosis and care, and it points to gaps across the country. The complete report and all state briefs are available at StateofAD.org.

“Eczema Awareness Month is about making sure people feel seen. The State of AD gives us the evidence to show that eczema deserves attention in every state, and the stories our community is sharing show why it matters. Together, they tell the whole story,” said Kristin Belleson, president and CEO of NEA.

Video stories: eczema in their own words

Alongside the data, NEA is sharing video testimonials from people living with eczema and the caregivers who support them. The data shows the scale of the need, and the stories show the people behind it. Watch the stories at EczemaMonth.org.

Ways to take part this October

NEA invites people with eczema, caregivers, health care professionals and partners to join the conversation:

Watch and share the video stories from the eczema community.

Explore the State of AD report and your state’s brief at StateofAD.org.

Use #UnhideEczema on social media to share your own experience.

Visit EczemaMonth.org for resources, events and more ways to get involved.

NEA thanks all the sponsors and partners who make Eczema Awareness Month possible, including our Platinum Sponsors: AbbVie, all® free clear, LEO Pharma, and Sanofi and Regeneron.

Frequently Asked Questions (FAQ)

Q: What is Eczema Awareness Month?
A: Eczema Awareness Month takes place every October. In 2026, it is centered on the State of Eczema, bringing together national data and personal stories from the eczema community.

Q: What is the State of AD?
A: The State of AD is a four-year initiative funded by the CDC. Its foundation is the State of Atopic Dermatitis Indicator Report and 51 state-level briefs, published Oct. 1, which set a national and state reference baseline on AD care and diagnosed prevalence.

Q: Where can I find the State of AD report?
A: The full report and all state briefs are available at StateofAD.org.

Q: How can I take part in Eczema Awareness Month?
A: Watch and share the stories, explore the report and use #UnhideEczema on social media.

The State of AD project was supported by the Grant or Cooperative Agreement Number 1 NU58DP007726-01-00, funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the U.S. Department of Health and Human Services.

About the National Eczema Association

Founded in 1988, the National Eczema Association (NEA) is a 501(c)(3) nonprofit and the largest patient advocacy organization serving the more than 31 million Americans living with eczema and those who care for them. NEA provides programs and resources to elevate the diverse lived experience of eczema, helping patients and caregivers understand their condition, actively engage in their care, find strength in one another and improve their lives. NEA also advances critical eczema research and partners with key stakeholders to ensure the patient voice is represented and valued in education, care and treatment decision-making. Learn more: NationalEczema.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/eczema-awareness-month-2026-what-is-the-state-of-eczema-today-302912799.html

SOURCE National Eczema Association

Continue Reading

Technology

In HelloNation, Electrical Expert Brennan Coffey Explains Why a Circuit Breaker Keeps Tripping

Published

on

By

The Article Explains Common Reasons a Circuit Breaker Trips and When the Pattern Signals a Bigger Problem.

SCHENECTADY, N.Y., Oct. 19, 2026 /PRNewswire/ — Why does a circuit breaker keep tripping? A HelloNation article answers that question and breaks down the most common reasons behind the problem.

The article explains that every circuit is built to carry a set amount of power safely. A circuit breaker cuts power once that limit is crossed, protecting the wiring from overheating before real damage occurs.

Each breaker in the panel protects one specific circuit, the article notes. An overloaded circuit will usually trip only its own breaker, not the entire panel. Homeowners often notice the pattern happens at predictable moments, like running a microwave and a toaster together.

According to the article, an overloaded circuit is one of the most common reasons a breaker trips. This often happens when several appliances draw power from the same outlets at once.

The article notes that kitchens are frequent trouble spots, since they run several high draw appliances from a limited number of outlets. Spreading large appliances across different circuits often solves the problem on its own.

A short circuit or a ground fault can also cause a circuit breaker to trip, the article explains, and both tend to act faster than a simple overload. A short circuit happens when a hot wire unexpectedly touches another wire.

A ground fault usually involves contact with a grounded surface, often because of moisture nearby. The article points out that GFCI outlets add protection in bathrooms and kitchens, though a standard breaker can still trip when a fault occurs elsewhere on the same circuit.

Newer homes may also have arc fault breakers, which sense the electrical pattern of an arc rather than a simple overload. These devices catch a hazard tied closely to house fires.

The article adds that an aging breaker can be the source of trouble in its own right, especially in a panel older than twenty years. Electrical Expert Brennan Coffey leads Coffey Electric & Generator, serving homeowners throughout the Schenectady area.

Homeowners should never open a panel cover or inspect breakers beyond resetting a switch, the article warns, since the panel carries live current even when a breaker has tripped. Forcing a stubborn breaker back on can let dangerous heat build inside the wall.

A breaker box that feels warm or shows scorch marks needs more urgency than routine tripping. That kind of heat points to trouble well beyond a simple overload, the article cautions.

The article suggests tracking when and where trips happen to spot a pattern before calling for help. Noting which appliances were running, and how often the issue repeats, gives a professional a useful starting point.

Waiting too long to address repeated trips can let a small issue grow into a larger and costlier one, the article explains. Addressing the pattern early tends to save both time and money down the road.

Electrical Expert Brennan Coffey is featured in the article, which advises against repeatedly resetting a breaker that keeps tripping without a clear cause. A licensed electrician can identify the underlying issue and determine what the repair actually requires.

Why Does a Circuit Breaker Keep Tripping? features insights from Brennan Coffey, Electrical Expert of Schenectady, New York, in HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused digital publications and innovative “edvertising” approach, HelloNation delivers expert-driven, good-news content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-electrical-expert-brennan-coffey-explains-why-a-circuit-breaker-keeps-tripping-302912791.html

SOURCE HelloNation

Continue Reading

Trending